ArticleRMD open2023

Long-lasting improvement of refractory antisynthetase syndrome with tocilizumab: a report of two cases.

Fleur Baumann Benvenuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.